Idoman
Idoman Teoranta is a privately held Irish medical device company that manufactures and globally distributes minimally invasive gynecological products — including the Thermablate thermal balloon ablation system, ExEm Foam Kit, Wing Needle, and Bioteque OB/GYN instruments — to gynecologists and women's health clinics across approximately 30 countries via direct sales and regional distributors.
- Company typePrivate
- Founded-
- HeadquartersToronto, Canada
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Idoman does
Idoman Teoranta is a privately held, founder-led medical device company headquartered in Tourmakeady, County Mayo, Ireland, where it also operates its manufacturing facility. The company is focused exclusively on minimally invasive gynecological products for women's health, with a portfolio built around four product lines: the Thermablate Endometrial Ablation System (EAS) — a thermal balloon technology that circulates heated glycerin (173°C fluid temperature, <100°C at the tissue interface) through a soft-tipped silicone balloon for a 2-minute-6-second endometrial ablation procedure; the ExEm Foam Kit for hysterosalpingo foam sonography (HyFoSy) used in tubal patency assessment; the Wing Needle, a 5mm curved hysteroscopic injection needle for intrauterine anesthesia delivery; and the Bioteque line of 100% medical-grade silicone OB/GYN instruments (pessaries, endometrial samplers, HSG catheters, dilators) which Idoman Canada distributes under an authorized arrangement.
The company generates revenue through hardware sales — a capital equipment plus recurring disposable cartridge model — and operates a hybrid go-to-market: direct sales via Idoman Canada (Toronto) and Idoman Teoranta (Ireland) for its two home markets, and a network of 25+ regional distributors covering approximately 30 countries across Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Target customers are practicing gynecologists and women's health clinics; pricing is not publicly disclosed, and product requests are routed through phone/email customer service. Idoman is privately owned with no disclosed institutional investors, no parent entity, and no headcount disclosed beyond a 1–10 employee range — a lean operating footprint that is unusual for a company with a 30-country commercial reach and is most likely enabled by reliance on distributor partners and outsourced manufacturing relationships.
The company holds ISO 13485:2016 (UKAS and MDSAP, valid through April 2029), CE Mark under Directive 93/42/EEC, and UKMDR registration (valid through April 2031), supporting legal market access in EU, UK, and MDSAP-participating jurisdictions. There is no disclosed venture capital, private equity, or public market activity, and the management team is not publicly listed.
Idoman firmographics
Firmographics- Name
- Idoman
- Legal name
- Idoman Teoranta
- Website
- https://idoman-med.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Idoman Teoranta is a privately held Irish medical device company that manufactures and globally distributes minimally invasive gynecological products — including the Thermablate thermal balloon ablation system, ExEm Foam Kit, Wing Needle, and Bioteque OB/GYN instruments — to gynecologists and women's health clinics across approximately 30 countries via direct sales and regional distributors.
- Ownership category
- akta.pro rank
Idoman industry classification
Industry- Product category
- Women's Health Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
- akta.pro secondary industry
- Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)
Keywords
Where Idoman is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Idoman business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Idoman generates revenue primarily through the sale of medical devices and disposable products including Thermablate EAS Treatment Control Units and disposable cartridges, ExEm Foam Kits, Wing Needles, and Bioteque OB/GYN products. Products are sold through direct sales and distributor networks.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Idoman product offering
Product offeringCore offering
Idoman Teoranta manufactures and distributes minimally invasive gynecological medical devices for women's health, including the Thermablate Endometrial Ablation System (EAS) for treating heavy menstrual bleeding, the ExEm Foam Kit for hysterosalpingo foam sonography (HyFoSy) tubal patency testing, the Wing Needle for intrauterine anesthesia delivery during hysteroscopic procedures, and distributes the Bioteque line of OB/GYN instruments in Canada. Products are sold through direct sales operations in Ireland and Canada, and a global distributor network spanning 25-30 countries.
Product overview
Idoman Teoranta offers a focused portfolio of minimally invasive gynecological medical devices. The core products include Thermablate EAS (a thermal balloon ablation system for treating heavy menstrual bleeding), ExEm Foam Kit (for hysterosalpingo foam sonography tubal patency testing), and Wing Needle (a hysteroscopic injection needle for intrauterine anesthesia). The company also distributes Bioteque's OB/GYN product line in Canada, which includes pessaries, endometrial samplers, and related gynecological instruments. All products are designed for women's health applications and are sold through a global network of distributors across 30 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Thermablate: Thermablate Endometrial Ablation System - a clinically proven treatment for heavy menstrual periods using thermal balloon ablation technology.
- ExEm
- Wing Needle
Products and services
- Thermablate EAS (Endometrial Ablation System)
- ExEm Foam Kit
- Wing Needle
- Bioteque OB/GYN Products (distributed in Canada)
Quantifiable outcome
- 98% of patients reported return to normal menstrual bleeding, hypomenorrhea or amenorrhea at 2 years
- +7 more outcomes
Companies that use Idoman
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
Idoman technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Idoman partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered regional and strategic.
- Gytech Pty. Ltd.regionalAustralian distributor for Thermablate EAS and Wing Needle products
- Kebomed Europe AGregionalEuropean distributor covering Austria, Denmark, Finland, Germany, Sweden, and Switzerland for Thermablate EAS and Wing Needle products
- June MedicalregionalUK distributor covering England, Scotland, and Wales for Thermablate EAS and Wing Needle products
- Medical Swan Italia S.a.SregionalEuropean distributor covering France and Italy for Thermablate EAS and Wing Needle products
- Sure Medical (Pty.) Ltd.regionalAfrican distributor covering Ghana, Namibia, and Republic of South Africa for Thermablate EAS and Wing Needle products
- Genomicks Sdn BhdregionalMalaysian distributor for Thermablate EAS and Wing Needle products
- Sage Healthcare Clinical ServicesregionalSingaporean distributor for Thermablate EAS and Wing Needle products
- FourMed FZLLCregionalUAE distributor for Thermablate EAS and Wing Needle products
- Medispar cvbaregionalBenelux distributor covering Belgium and Netherlands for Thermablate EAS and Wing Needle products
- AMI Medical TechnologiesregionalIsraeli distributor for Thermablate EAS and Wing Needle products
- IntermedregionalNew Zealand distributor for Thermablate EAS and Wing Needle products
- Sistemas Administrativos Médicos, S.A. de C.V.regionalMexican distributor for Thermablate EAS and Wing Needle products
- Premier Medical Ltd.regionalIrish distributor for Thermablate EAS and Wing Needle products
- Idoman CanadaregionalCanadian distributor for Thermablate EAS and Wing Needle products, with separate operations covering Bermuda market
- Bioteque America IncstrategicBioteque specializes in OB/GYN products since 1992, offering pessaries, endometrial samplers, dilators, HSG catheters, curettes, and uterine sounds. Idoman Canada is authorized distributor of Bioteque's gynecological product line in Canada
Scale indicators9 records
Recent moves5 records
Expansion highlights5 records
Idoman competitors and assessment
Company assessmentDirect peers
- Stryker: Stryker's gynecology surgical instruments and hysteroscopic device portfolio overlap directly with Idoman's minimally invasive gynecologic surgery product range and global distribution strategy.
- Boston Scientific: Boston Scientific owns the Genesys HTA hydrothermal ablation system, a direct Thermablate competitor in the global endometrial ablation market with significantly larger commercial scale and clinical evidence investment.
- Olympus Medical: Olympus Medical manufactures operative hysteroscopes and accessories that compete with Idoman's Wing Needle and consumables in the hysteroscopy procedure workflow.
- Minerva Surgical: Minerva Surgical offers the Minerva endometrial ablation system and Acessa fibroid treatment, directly competing with Thermablate in the minimally invasive gynecologic procedure category Idoman serves.
- Richard Wolf Medical Instruments: Richard Wolf offers hysteroscopic and resectoscopic instruments used in the same minimally invasive gynecologic procedure category served by Idoman's Wing Needle hysteroscopic injection system.
- Hologic: Hologic markets NovaSure, the global category-leading endometrial ablation device, competing head-to-head with Idoman's Thermablate EAS for the same gynecologist call point and heavy menstrual bleeding patient population.
- CooperSurgical: CooperSurgical provides a broad portfolio of OB/GYN devices including endometrial sampling, pessaries, and hysteroscopic instruments that overlap directly with Idoman's Bioteque distribution line and core women's health focus.
- Karl Storz: Karl Storz is a global leader in hysteroscopic visualization and instrumentation, comparable to Idoman's Wing Needle working-channel hysteroscopic injection device used in the same gynecologic procedures.
- Cook Medical: Cook Medical provides HSG catheters, gynecologic devices and fertility diagnostic tools that directly overlap with Idoman's ExEm Foam Kit tubal patency offering and Bioteque HSG catheter distribution line.
Emerging players
- Rocket Medical: Rocket Medical focuses on HSG, fertility and hysteroscopic instrumentation in the UK and selected export markets, providing a more focused emerging-player analog to Idoman's niche women's health diagnostic and procedural device portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Idoman social profiles
Digital presenceIdoman compliance and trust
Trust signalCompliance3 records
Idoman financial estimates
Financial estimateRevenue estimate
Valuation estimate
Idoman leadership team
Management profileNumber of profiles
Idoman subsidiaries and ownership
Company hierarchySubsidiaries2 records
Idoman funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Idoman M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Idoman
What does Idoman do?
Idoman Teoranta manufactures and distributes minimally invasive gynecological medical devices for women's health, including the Thermablate Endometrial Ablation System (EAS) for treating heavy menstrual bleeding, the ExEm Foam Kit for hysterosalpingo foam sonography (HyFoSy) tubal patency testing, the Wing Needle for intrauterine anesthesia delivery during hysteroscopic procedures, and distributes the Bioteque line of OB/GYN instruments in Canada. Products are sold through direct sales operations in Ireland and Canada, and a global distributor network spanning 25-30 countries.
Is Idoman a public or private company?
Idoman is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Idoman founded?
Idoman was founded in -1. It employs 1 to 10 people.
Where is Idoman based?
Idoman is headquartered in Toronto, Canada, in the North America region.
How does Idoman make money?
One revenue line is on record: medical Device Sales.
Who are Idoman's main competitors?
Direct peers on record are Stryker, Boston Scientific, Olympus Medical, Minerva Surgical, Richard Wolf Medical Instruments, Hologic, CooperSurgical, Karl Storz and Cook Medical. Rocket Medical is listed as an emerging player.
Does Idoman have an API?
No public API is recorded for Idoman.
What industry is Idoman in?
Idoman's product category is Women's Health Medical Devices. Its primary akta.pro industry code is HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools), with a secondary code of HLAHANAG, Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs). Its NAICS code is 339113 and its SIC code is 3841.